The field of atopic dermatitis (AD) has been receiving great interest over the last few years with the approvals of both oral ...

The U.S. Food and Drug Administration (FDA) announced the target action date of its review of the sNDA for VTAMA (tapinarof) cream, 1% has changed.

Biologic treatments are a new option for people with moderate to severe eczema or atopic dermatitis. Most people can control eczema with prevention techniques, topical treatments, or ultraviolet ...

Long-term treatment of adolescents with moderate-to-severe atopic dermatitis (AD) with upadacitinib is safe and effective through 76 weeks.

Atopic dermatitis can have a significant impact on quality of life in adolescents, so new efficient treatments are needed to ...

The new app addresses a skin disorder – commonly known as eczema – that affects ... Cibinqo (abrocitinib) as a treatment for moderate-to-severe atopic dermatitis in adults who cannot get ...

Dermavant Sciences has shared positive long-term results for its plaque psoriasis-approved Vtama (tapinarof) cream in adults ...

He is spearheading the Danish Atopic Dermatitis Register for Systemic Treatment (SCRATCH) and providing strategic consultations and advice for the pharmaceutical industry based on his extensive ...

Prior treatment use did not affect the efficacy or safety of topical ruxolitinib cream 1.5% for up to 52 weeks among patients with atopic dermatitis.

November is Eczema Awareness Month, and Eczema Society of Canada (ESC) has secured monuments and landmarks across Canada to light up blue to "shine a light" on the burden and impact of eczema and ...

U.S. drugmaker Regeneron Pharmaceuticals beat Wall Street estimates for third-quarter profit and revenue on Thursday, driven ...

Learn about the benefits and risks of probiotic supplements and how to choose the best one for your health goals.